Pessimistic Wright Medical wins FDA date for Augment

Wright Medical says it's not optimistic about an FDA dispute resolution panel this May on its Augment biologic bone graft. Wright Medical (NSDQ:WMGI) said it's not optimistic about an FDA dispute resolution panel on its Augment biologic bone graft product, now slated for May, and would quickly move to cut costs at the BioMimetic Therapeutics subsidiary it bought back in 2012. Wright Medical Group Inc., BioMimetic Therapeutics Inc.News Well, MassDevice.com Earnings Roundup, 2013, Orthobiologics, Orthopedics, Q4read more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news